LOC101928635: A Potential Drug Target or Biomarker (G101928635)

LOC101928635: A Potential Drug Target or Biomarker

LOC101928635 (LOC101928635 variant X9) is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a member of the family of transmembrane proteins, which means that it spans the cell membrane and extends into the cytoplasm.

LOC101928635 variant X9 is of particular interest as a potential drug target or biomarker because of its involvement in various physiological processes in the body. For example, it has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. Additionally, LOC101928635 has been shown to play a role in the regulation of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain.

The discovery and characterization of LOC101928635 variant X9 was made by researchers at the University of California, San Diego. They used a variety of techniques, including mass spectrometry and biochemical assays, to identify and characterize this protein. Subsequent studies have further demonstrated its involvement in various physiological processes, including the regulation of cell adhesion and the blood-brain barrier.

In addition to its potential drug-targeting properties, LOC101928635 variant X9 also has potential as a biomarker. The blood-brain barrier is a specialized barrier that separates the brain from the surrounding blood vessels, and it is difficult to study. By using LOC101928635 variant X9 as a biomarker, researchers can study the regulation of cell adhesion and the blood-brain barrier in a more controlled and reliable manner than with traditional methods.

Another potential application of LOC101928635 variant X9 as a biomarker is its potential to serve as a target for small molecules. The protein is involved in the regulation of cell adhesion, which is a critical process in the development and maintenance of tissues and organs. By identifying small molecules that can modulate cell adhesion, researchers may be able to develop new treatments for a variety of diseases.

LOC101928635 variant X9 is also of interest as a potential drug target for its role in the regulation of the blood-brain barrier. The blood-brain barrier is responsible for controlling the movement of substances into and out of the brain, and it is difficult to study. By using LOC101928635 variant X9 as a biomarker or drug target, researchers may be able to develop new treatments for a variety of neurological and psychiatric disorders.

In conclusion, LOC101928635 (LOC101928635 variant X9) is a protein that is expressed in various tissues of the human body that is of potential interest as a drug target or biomarker. Its involvement in the regulation of cell adhesion and the blood-brain barrier makes it an attractive target for small molecules and new treatments for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its potential and to develop new treatments based on it.

Protein Name: Uncharacterized LOC101928635, Transcript Variant X3

The "LOC101928635 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101928635 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861 | LOC101928864 | LOC101928890 | LOC101928893 | LOC101928894 | LOC101928911 | LOC101928912 | LOC101928923 | LOC101928940 | LOC101928947 | LOC101928948 | LOC101928950 | LOC101928972 | LOC101929003 | LOC101929048 | LOC101929073 | LOC101929085 | LOC101929098 | LOC101929106 | LOC101929129 | LOC101929130 | LOC101929133 | LOC101929174 | LOC101929200 | LOC101929208 | LOC101929219 | LOC101929237 | LOC101929256 | LOC101929258 | LOC101929268 | LOC101929279 | LOC101929298 | LOC101929309 | LOC101929372 | LOC101929401 | LOC101929418 | LOC101929419 | LOC101929439 | LOC101929452 | LOC101929457 | LOC101929460 | LOC101929470 | LOC101929485 | LOC101929491 | LOC101929506 | LOC101929532 | LOC101929536 | LOC101929551 | LOC101929555 | LOC101929563 | LOC101929578 | LOC101929615 | LOC101929622 | LOC101929633 | LOC101929698 | LOC101929707 | LOC101929710 | LOC101929713 | LOC101929718 | LOC101929727 | LOC101929755 | LOC101929761 | LOC101929762 | LOC101929772 | LOC101929788 | LOC101929996 | LOC101930053 | LOC101930071 | LOC101930098 | LOC101930112 | LOC101930129 | LOC101930496 | LOC102723311 | LOC102723313 | LOC102723321 | LOC102723323 | LOC102723340 | LOC102723341 | LOC102723342 | LOC102723345 | LOC102723364 | LOC102723370